Institutional Ownership Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE). We have compiled data on the 155 institutions that hold shares in the stock, with a total of 81.5 Million shares, which have been reported (via 13F filing form) to have a value of $78.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
12,872,946
shares
|
$12.4 Million
1.79% of portfolio
|
Q4 2024
Reduced 2.25%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,116,106
shares
|
$9.71 Million
0.0% of portfolio
|
Q2 2024
Added 11.17%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
8,798,491
shares
|
$8.45 Million
0.0% of portfolio
|
Q3 2025
Added 0.36%
|
|
|
Wilshire Advisors LLC
Santa Monica, CA |
Nov 14, 2025 Q3 2025 |
8,486,822
shares
|
$8.15 Million
27.71% of portfolio
|
Q3 2025
New holding
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Nov 13, 2025 Q3 2025 |
3,379,064
shares
|
$3.24 Million
1.0% of portfolio
|
Q3 2021
New holding
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
2,710,234
shares
|
$2.6 Million
0.01% of portfolio
|
Q3 2025
Added 10.17%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
2,530,212
shares
|
$2.43 Million
0.0% of portfolio
|
Q3 2025
Added 4.16%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,515,000
shares
|
$2.41 Million
0.14% of portfolio
|
Q2 2025
Reduced 0.03%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,417,135
shares
|
$2.32 Million
0.0% of portfolio
|
Q3 2025
Added 8.43%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
2,094,975
shares
|
$2.01 Million
0.0% of portfolio
|
Q3 2025
Reduced 14.06%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
1,867,773
shares
|
$1.79 Million
0.11% of portfolio
|
Q1 2025
Added 0.64%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,486,407
shares
|
$1.43 Million
0.0% of portfolio
|
Q3 2025
Reduced 40.82%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
1,262,515
shares
|
$1.21 Million
0.0% of portfolio
|
Q3 2025
Added 488.69%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
1,131,414
shares
|
$1.09 Million
0.0% of portfolio
|
Q3 2025
Added 33.7%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,090,260
shares
|
$1.05 Million
0.01% of portfolio
|
Q2 2023
Reduced 9.09%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
1,007,400
shares
|
$967,104
0.0% of portfolio
|
Q3 2025
Added 104.3%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
963,871
shares
|
$925,316
0.0% of portfolio
|
Q3 2025
Added 9.57%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
929,944
shares
|
$892,746
0.0% of portfolio
|
Q3 2025
Reduced 61.79%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
900,757
shares
|
$864,726
0.0% of portfolio
|
Q3 2025
Added 294.37%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
824,545
shares
|
$791,563
0.0% of portfolio
|
Q3 2025
Reduced 81.85%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
814,639
shares
|
$782,053
0.0% of portfolio
|
Q3 2025
Reduced 32.88%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
814,465
shares
|
$781,886
0.0% of portfolio
|
Q3 2025
Reduced 3.54%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
785,921
shares
|
$754,484
0.0% of portfolio
|
Q3 2025
Added 7.09%
|
|
|
Monaco Asset Management Sam
|
Nov 10, 2025 Q3 2025 |
770,000
shares
|
$739,200
0.06% of portfolio
|
Q3 2025
Added 14.07%
|
|
|
Bruce & Co., Inc.
Chicago, IL |
Nov 13, 2025 Q3 2025 |
729,188
shares
|
$700,020
0.37% of portfolio
|
Q3 2025
Added 69.9%
|
|